“…Our interest is focused on rhodanine (2-sulfanylidene-1,3-thiazolidin-4-one) derivatives, which were synthesized in our laboratory and tested for their biological activities [ 9 , 10 , 11 , 12 , 13 ]. Derivatives of rhodanine show a broad spectrum of biological activities, e.g., antibacterial, antifungal, antitubercular, anticancer, antidiabetic, anti-inflammatory and antiparasitic activities [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ]. Given the high potency of rhodanine derivatives as bioactive agents, we have evaluated cinnamylidene derivatives of rhodanine towards their anthelmintic activity.…”